PERIOPERATIVE CONSIDERATIONS FOR GLP-1RAS AND GIP/GLP-1RA THERAPY Increased residual gastric content There is emerging evidence that the use of GLP-1 receptor agonists is associated with increased RGC, based on studies in patients undergoing endoscopy, despite fasting for at least 8 hours [68]
evaluated the effectiveness and tolerability of high-dose escitalopram in patients with OCD
[4] Your own result may be higher or lower, so the safest way to judge progress is through regular clinical review
Quick Answer: Yes, you can generally use your HSA or FSA funds to pay for GLP-1 medications like semaglutide and tirzepatide, provided they are prescribed by a licensed healthcare provider for a diagnosed medical condition such as obesity or type 2 diabetes
While the FDA does not specifically prohibit plasma donation for tirzepatide users, eligibility depends on individual health status, disease control, medication side effects, and donation center policies
Most side effects are mild to moderate and tend to improve as the body adjusts